Impact of Thrombotic Microangiopathy on Renal Outcomes and Survival after Hematopoietic Stem Cell Transplantation-Reference-Cited by-同舟云学术

Impact of Thrombotic Microangiopathy on Renal Outcomes and Survival after Hematopoietic Stem Cell Transplantation

Published:2018-11 Issue:11 Volume:24 Page:2344-2353
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Postalcioglu Merve,Kim Haesook T.,Obut Faruk,Yilmam Osman Arif,Yang Jiqiao^ORCID,Byun Benjamin C.,Kupiec-Weglinski Sophie,Soiffer Robert,Ritz Jerome^ORCID,Antin Joseph H.,Alyea Edwin,Koreth John,Cutler Corey,Armand Philippe,Paik Julie M.,Leaf David E.,Ho Vincent T.,Abdi Reza

Funder

Alexion Pharmaceuticals Inc.

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference17 articles.

1. Syndromes of thrombotic microangiopathy;George;N Engl J Med,2014

2. Atypical hemolytic-uremic syndrome;Noris;N Engl J Med,2009

3. Blood and marrow transplant clinical trials network toxicity committee consensus summary: thrombotic microangiopathy after hematopoietic stem cell transplantation;Ho;Biol Blood Marrow Transplant,2005

4. Thrombotic thrombocytopenic purpura-hemolytic uremic syndrome following allogeneic HPC transplantation: a diagnostic dilemma;George;Transfusion,2004

5. Transplant-associated microangiopathy in patients receiving tacrolimus following allogeneic stem cell transplantation: risk factors and response to treatment;Oran;Biol Blood Marrow Transplant,2007

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Thrombotic complications after hematopoietic stem cell transplantation and other cellular therapies;Thrombosis Update;2024-09

2. Real-world analysis of the underdiagnosis, clinical outcomes and associated burden of hematopoietic stem cell transplantation-associated thrombotic microangiopathy (HSCT-TMA) in the United States;Frontiers in Hematology;2024-07-15

3. Neurologic Complications of the Central Nervous System after Allogeneic Stem Cell Transplantation: The Role of Transplantation-Associated Thrombotic Microangiopathy as a Potential Underreported Cause;Transplantation and Cellular Therapy;2024-06

4. Successful use of narsoplimab to treat allogeneic transplant-associated thrombotic microangiopathy while maintaining sirolimus;Bone Marrow Transplantation;2024-03-11

5. Thrombotic Microangiopathy After Hematopoietic Stem Cell and Solid Organ Transplantation: A Review for Intensive Care Physicians;Journal of Intensive Care Medicine;2023-11-21